Boundless Bio, Inc.

NASDAQ:BOLD

Biotechnology

Healthcare
$2.38 +85.71%

+$1.20 today

Market cap
$56.20M
Beta
0.97
P/E (TTM)
-1.0
EPS (TTM)
-$2.50
52W Low $0.96High $2.75

Volume 0.13M

Average 0.22M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$63.55M

FY 2025 · Annual

Net Income

-$58.20M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue0001.09M1.25M
Gross Profit000(1.09M)(1.25M)
Gross Margin—————
Research & Development19.28M37.16M42.64M55.27M44.85M
Selling, General & Admin6.02M9.31M12.16M18M18.71M
Operating Expenses25.3M46.47M54.8M72.18M62.3M
Depreciation & Amortization682K942K957K1.09M1.25M
EBITDA(24.53M)(44.96M)(48.48M)(64.28M)(56.95M)
EBITDA Margin—————
Operating Income(25.3M)(46.47M)(54.8M)(73.27M)(63.55M)
Operating Margin—————
Interest Income96K668K5.28M7.89M5.36M
Interest Expense00000
Other Income / Expenses91K568K5.36M7.9M5.36M
Income Before Tax(25.21M)(45.9M)(49.43M)(65.36M)(58.2M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(25.21M)(45.9M)(49.43M)(65.36M)(58.2M)
Net Margin—————
EPS (Basic)(1.13)(2.06)(2.22)(3.85)(2.60)
EPS (Diluted)(1.13)(2.06)(2.22)(3.85)(2.60)
Weighted Avg Shares22.24M22.24M22.24M16.98M22.36M
Weighted Avg Shares (Diluted)22.24M22.24M22.24M16.98M22.36M

BOLD Earnings Waterfall · TTM

NASDAQ:BOLD · Revenue to Net Income

Key Ratios

EPS$-2.50
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.5
P/S Ratio0.0

Analysis

$0 of revenue converted into -$56.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-2.50, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 10, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
EFFECTEFFECT filingNov 3, 2026
424B3424B3 filingNov 3, 2026

How much revenue does BOLD generate?

Boundless Bio, Inc. (BOLD) reported $0.00 of revenue in fiscal 2025.

Is BOLD profitable?

Boundless Bio, Inc. (BOLD) reported -$58.20M of net income.